Claris Lifesciences Ltd

Claris Lifescien Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Claris Lifesciences Ltd

₹ 397 -0.06%
14 Mar 2018
clarislifesciences.com
About

Claris Lifesciences Limited is engaged in manufacturing of drugs and pharmaceutical products.

[ add key points ]
Website
  • Market Cap ₹ 2,164 Cr.
  • Current Price ₹ 397
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -2.14
  • Dividend Yield 0.00 %
  • ROCE -2.85 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017
183 158 187 197 26 18 1 2 5 3 3 4 2
136 134 141 184 65 39 16 27 39 21 22 16 375
Operating Profit 47 24 46 13 -40 -21 -15 -25 -34 -19 -19 -11 -373
OPM % 26% 15% 25% 6% -155% -114% -1,104% -1,411% -752% -676% -611% -264% -18,034%
27 14 8 21 33 17 40 56 44 53 38 1,865 59
Interest 11 10 10 11 1 2 1 4 1 1 1 1 1
Depreciation 9 9 10 4 1 1 2 -0 1 2 1 1 1
Profit before tax 53 18 34 18 -8 -7 22 27 8 32 17 1,852 -316
Tax % -70% 30% 37% 24% -276% -91% 1% -20% -121% -17% -16% 1% 1%
90 10 19 12 -70 -1 22 32 19 37 19 1,840 -317
EPS in Rs 16.47 1.91 3.53 2.20 -12.84 -0.11 4.03 5.94 3.40 6.77 3.52 337.24 -58.17
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 15m Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
743.52 752.34 740.49 767.36 667.76 799.76 133.16 0.00 0.00 0.00 0.00 0.00
510.97 514.86 494.25 502.55 521.49 661.69 267.16 10.64 25.19 12.47 1.46 0.31
Operating Profit 232.55 237.48 246.24 264.81 146.27 138.07 -134.00 -10.64 -25.19 -12.47 -1.46 -0.31
OPM % 31.28% 31.57% 33.25% 34.51% 21.90% 17.26% -100.63%
9.23 16.46 15.33 10.29 78.76 103.71 80.99 120.14 42.57 7.63 0.46 0.04
Interest 53.26 46.75 55.43 65.05 52.19 48.26 5.48 0.00 0.00 0.00 0.00 0.00
Depreciation 44.81 46.72 54.68 74.27 65.35 49.05 3.86 0.14 0.10 0.00 0.00 0.00
Profit before tax 143.71 160.47 151.46 135.78 107.49 144.47 -62.35 109.36 17.28 -4.84 -1.00 -0.27
Tax % 9.28% 11.86% 16.64% 23.47% 20.54% -8.45% -36.74% -0.51% 9.90% 54.75% 401.00% 0.00%
130.37 141.44 126.25 103.91 84.41 149.48 -39.44 109.93 15.56 -7.49 -5.01 -0.27
EPS in Rs 22.16 19.78 16.28 13.23 27.39 -7.23 20.15 3.12 -1.37 -0.92 -0.05
Dividend Payout % 7.85% 9.02% 10.11% 12.28% 68.05% 0.00% -27.67% 9.93% 64.20% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: 14%
3 Years: %
TTM: 95%
Stock Price CAGR
10 Years: 10%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity Capital 34.12 63.82 63.82 63.82 63.82 54.57 54.57 54.57 54.57 54.57 54.57 54.57
Reserves 476.08 851.17 988.29 1,085.05 1,340.48 1,262.14 864.94 965.37 -53.86 -60.94 -65.96 -66.23
314.01 360.63 408.64 542.09 267.78 533.82 598.73 21.56 0.00 0.00 20.97 21.01
531.62 418.91 269.86 311.34 438.84 333.25 229.06 740.65 23.31 28.10 0.40 0.43
Total Liabilities 1,355.83 1,694.53 1,730.61 2,002.30 2,110.92 2,183.78 1,747.30 1,782.15 24.02 21.73 9.98 9.78
492.03 530.60 663.27 870.60 571.57 1,074.29 866.17 56.41 0.00 0.00 0.00 0.00
CWIP 123.23 233.57 41.92 174.27 173.29 2.83 10.42 2.40 0.00 0.00 0.00 0.00
Investments 0.02 0.02 0.02 0.02 818.32 533.92 308.28 291.26 0.00 0.00 0.00 0.00
740.55 930.34 1,025.40 957.41 547.74 572.74 562.43 1,432.08 24.02 21.73 9.98 9.78
Total Assets 1,355.83 1,694.53 1,730.61 2,002.30 2,110.92 2,183.78 1,747.30 1,782.15 24.02 21.73 9.98 9.78

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
380.80 69.67 -18.93 334.18 143.38 -41.43 20.46 179.35 -5.82 -0.15 6.17 -0.11
-103.81 -191.86 -221.22 -436.61 197.01 -122.86 56.80 -58.46 -133.48 0.35 0.41 0.05
-56.95 280.86 -24.20 58.27 -342.88 152.21 22.28 -105.49 -13.14 0.00 -6.67 -0.01
Net Cash Flow 220.04 158.67 -264.35 -44.16 -2.49 -12.07 99.54 15.41 -152.44 0.21 -0.09 -0.06
Free Cash Flow 279.12 -126.44 -253.43 -108.85 924.15 -258.70 -90.95 108.80 3.18 -0.15 6.17 -0.11
CFO/OP 182% 39% -1% 136% 110% 6% -40% -2,440% 12% 1% -41% 35%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Debtor Days 129.98 119.54 135.04 108.56 85.55 104.58 458.91
Inventory Days 202.51 236.25 227.47 268.54 66.44 96.51 337.48
Days Payable 268.75 207.26 107.34 156.09 110.97 130.52 518.84
Cash Conversion Cycle 63.74 148.52 255.17 221.01 41.02 70.57 277.55
Working Capital Days 11.65 81.48 199.37 152.54 -62.96 71.29 336.30
ROCE % 26.23% 19.78% 15.17% 12.74% 8.29% 9.95% -1.23% 8.54% 1.92% -62.31% -2.85%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017
ANDAs Approved (USA)
Number of Approvals

Log in to view insights

Please log in to see hidden values.

Login
Direct Permanent Employees
Number of Persons
Manufacturing Capacity (Injectables)
Million Units per Year
Number of Pharmacists in Workforce
Number
Revenue Contribution - USA Market (SIB)
Percentage of SIB Sales
Total ANDAs Filed (USA)
Number of Applications
Total Manpower (Employees + Contract)
Number of Persons

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017
60.99% 52.56% 50.13% 50.13% 50.13% 50.13% 50.13%
20.29% 25.43% 25.86% 26.48% 26.22% 25.62% 26.02%
1.35% 1.35% 1.49% 1.86% 1.86% 1.94% 1.94%
17.36% 20.66% 22.52% 21.53% 21.79% 22.31% 21.91%
No. of Shareholders 20,98320,54920,11719,65918,19817,90217,032

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings